Indian Oxaliplatin Exporters: Complete Supplier Ranking with Market Share — 249 Manufacturers (2026) — TransData Nexus

Q: Who is the largest oxaliplatin supplier from India?

FRESENIUS KABI ONCOLOGY LIMITED is the largest oxaliplatin exporter from India with a 35.7% market share and export value of $16.6M.

Q: How many oxaliplatin suppliers are there in India?

There are 249 active oxaliplatin exporters in India, collectively shipping $46.6M worth of oxaliplatin across 3,081 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top oxaliplatin suppliers from India?

The top 5 oxaliplatin suppliers from India — FRESENIUS KABI ONCOLOGY LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ACCURE LABS PRIVATE LIMITED, GLAND PHARMA LIMITED — together control 66.1% of total oxaliplatin export value from India.

Suresh Sormare

Oxaliplatin

India Pharmaceutical Trade Intelligence

$46.6M249 Suppliers123 CountriesHS 30049049

ExportsIndia → GERMANY21.5%India → RUSSIA13.9%

ImportsARGENTINA → India$44.5K ITALY → India$20.0K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Oxaliplatin Suppliers from India (2026) — 249 Exporters, $46.6M Market | TransData Nexus | TransData Nexus

Who Exports Oxaliplatin from India — 249 Suppliers Behind a $46.6M Market

India's oxaliplatin export market is supplied by 249 active exporters who collectively shipped $46.6M across 3,081 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 35.7% market share, followed by JODAS EXPOIM PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 66.1% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Oxaliplatin Suppliers & Exporters — 249 manufacturers, $46.6M export market, top destinations and formulations — Oxaliplatin supplier data — 249 exporters · $46.6M market · 3,081 shipmentsTransData Nexus · Indian Customs Data

Top Oxaliplatin Exporters from India — Ranked by Export Value

FRESENIUS KABI ONCOLOGY LIMITED is the leading oxaliplatin exporter from India, holding a 35.7% share of the $46.6M market across 3,081 shipments from 249 exporters. The top 5 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ACCURE LABS PRIVATE LIMITED, GLAND PHARMA LIMITED — collectively control 66.1% of total export value, indicating a moderately concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (35.7%), JODAS EXPOIM PRIVATE LIMITED (12.5%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (7.7%), ACCURE LABS PRIVATE LIMITED (5.5%), GLAND PHARMA LIMITED (4.7%).

Top Oxaliplatin Exporters from India

Ranked by export value · 249 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Oxaliplatin Exporters from India — Ranked by Export Value. 249 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Oxaliplatin — Export Intelligence Video

Visual overview of India's oxaliplatin supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's oxaliplatin pharmaceutical supplier landscape — $46.6M in total trade, 249 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Oxaliplatin exporters

Certification and compliance status for top Oxaliplatin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
FRESENIUS KABI ONCOLOGY LIMITED	Not Listed	Yes, as of November	No	Not verified	WHO-GMP certified; no FDA listing found.
GLAND PHARMA LIMITED	Not Listed	Yes, date unspecifie	No	Not verified	WHO-GMP certified; no FDA listing found.
MYLAN LABORATORIES LIMITED	Not Listed	Yes, as of April 202	No	Not verified	WHO-GMP certified; no FDA listing found.
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Not Listed	Yes, as of September	No	Not verified	WHO-GMP certified; no FDA listing found.
NAPROD LIFE SCIENCES PRIVATE LIMITED	Not Listed	Yes, date unspecifie	No	Not verified	WHO-GMP certified; no FDA listing found.
VENUS REMEDIES LIMITED	Not Listed	Yes, date unspecifie	No	Not verified	WHO-GMP certified; no FDA listing found.
INTAS PHARMACEUTICALS LIMITED	Not Listed	Yes, date unspecifie	No	Not verified	WHO-GMP certified; no FDA listing found.
DR. REDDY'S LABORATORIES LTD	Not Listed	Yes, date unspecifie	No	Not verified	WHO-GMP certified; no FDA listing found.

TransData Nexus reviewed the regulatory standing of 8 leading Oxaliplatin exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Oxaliplatin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a central hub for pharmaceutical manufacturing and research. The city contributes approximately 40% of the country's bulk drug production, underscoring its significance in the pharmaceutical sector. The establishment of Genome Valley, a premier biotech cluster, has attracted over 200 life sciences companies, including global giants such as Novartis, Bayer, and Sanofi. This ecosystem fosters innovation and large-scale production, making Hyderabad a key player in the global pharmaceutical supply chain.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara serving as major pharmaceutical hubs. The region is home to several large pharmaceutical companies, including Sun Pharmaceuticals, Cadila Pharmaceuticals, Torrent Pharmaceuticals, Alembic Pharmaceuticals, Intas Pharmaceuticals, and Zydus Lifesciences. These companies have established a strong presence in both domestic and international markets, contributing significantly to the pharmaceutical industry's growth.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Oxaliplatin exporters from India

March 2023

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Concert Pharmaceuticals for dermatology expansion

Sun Pharma completed the acquisition of Concert Pharmaceuticals, a late-stage clinical biopharmaceutical company developing deuruxolitinib, an oral JAK1/2 inhibitor for treating alopecia areata. - IMPACT: This acquisition enhances Sun Pharma's dermatology portfolio, potentially increasing its market share and resources for Oxaliplatin exports.

Impact: This acquisition enhances Sun Pharma's dermatology portfolio, potentially increasing its market share and resources for Oxaliplatin exports.

January 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma to acquire remaining stake in Taro Pharmaceutical

Sun Pharma agreed to acquire the remaining 21.52% stake in Taro Pharmaceutical Industries, aiming to strengthen its dermatology portfolio and presence in the US and Canadian markets. - IMPACT: This consolidation may lead to increased operational efficiencies, potentially benefiting Sun Pharma's Oxaliplatin export capabilities.

Impact: This consolidation may lead to increased operational efficiencies, potentially benefiting Sun Pharma's Oxaliplatin export capabilities.

Common Questions — Oxaliplatin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which oxaliplatin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, FRESENIUS KABI ONCOLOGY LIMITED leads with 602 recorded shipments worth $16.6M. JODAS EXPOIM PRIVATE LIMITED (32 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (113 shipments) are also established high-volume exporters.

Q How many oxaliplatin manufacturers are there in India?

India has 249 active oxaliplatin exporters with a combined export market of $46.6M across 3,081 shipments to 123 countries. The top 5 suppliers hold 66.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for oxaliplatin from India?

Average FOB unit price: $11.37 per unit, ranging from $0.01 to $1089.32. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Oxaliplatin

Oxaliplatin

Who Exports Oxaliplatin from India — 249 Suppliers Behind a $46.6M Market

Top Oxaliplatin Exporters from India — Ranked by Export Value

Top Oxaliplatin Exporters from India

Related Analysis

Need Details?

Oxaliplatin — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Concert Pharmaceuticals for dermatology expansion

Sun Pharmaceutical Industries Limited — Sun Pharma to acquire remaining stake in Taro Pharmaceutical

Common Questions — Oxaliplatin Suppliers from India

Q Which oxaliplatin supplier from India is the most reliable for bulk orders?

Q How many oxaliplatin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for oxaliplatin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Fresenius Kabi Oncology Limited — Teva and mAbxience enter global licensing agreement for oncology biosimilar

Analysis Methodology